Skip to main content

Advertisement

Log in

Pregnane X Receptor Not Nuclear Factor-kappa B Up-regulates P-glycoprotein Expression in the Brain of Chronic Epileptic Rats Induced by Kainic Acid

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Drug-resistance epilepsy (DRE) is attributed to the brain P-glycoprotein (P-gp) overexpression. We previously reported that nuclear factor-kappa B (NF-κB) played a critical role in regulating P-gp expression at the brain of the acute seizure rats. This study was extended further to investigate the interaction effect of NF-κB and pregnane X receptor (PXR) on P-gp expression at the brain of chronic epileptic rats treated with carbamazepine (CBZ). The chronic epileptic models were induced by the micro-injection of kainic acid (KA) into rats’ hippocampus. Subsequently, the successful models were treated with different intervention agents of CBZ; PMA(a non-specific PXR activity inhibitor) or PDTC(a specific NF-κB activity inhibitor) respectively. The expression levels of P-gp and its encoded gene mdr1a/b were significantly up-regulated on the brain of KA-induced chronic epilepsy rats or the epilepsy rats treated with CBZ for 1 week, meanwhile with a high expression of PXR. The treatment of PMA dramatically reduced both PXR and P-gp expressions at the protein and mRNA levels in the chronic epilepsy brain. By compared to the epilepsy model group, the P-gp expression was not markedly attenuated by the inhibition of NF-κB activity with PDTC treatment, nevertheless with a decrease of NF-κB expression in this intervention group. Higher levels of proinflammatory cytokines(IL-1β, IL-6, TNF-α) were found both in the brain tissue and the serum in the epilepsy rats of each group. There was a declined trend of the pro-inflammatory cytokines expression of the PDTC treatment group but with no statistical significance. This study demonstrates for the first time that P-gp up-regulation is due to increase PXR expression in the chronic phase of epilepsy, differently from that NF-κB signaling may induce the P-gp expression in the acute seizure phase. Our results offer insights into the mechanism underlying the development of DRE using or not using CBZ treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Marras CE, Canevini MP, Colicchio G et al (2013) Health technology assessment report on the presurgical evaluation and surgical treatment of drug-resistant epilepsy[J]. Epilepsia 54(s7):49–58

    Article  PubMed  Google Scholar 

  2. Kwan P, Schachter SC, Brodie MJ (2011) Drug-resistant epilepsy[J]. N Engl J Med 365(10):919–926

    Article  CAS  PubMed  Google Scholar 

  3. Xiong J, Mao D, Liu L (2015) Research progress on the role of ABC transporters in the drug resistance mechanism of intractable epilepsy[J]. BioMed Res Int 2015:1.

    Google Scholar 

  4. Sisodiya SM, Lin WR, Harding BN et al (2002) Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy[J]. Brain 125(1):22–31

    Article  CAS  PubMed  Google Scholar 

  5. Zhang C, Kwan P, Zuo Z et al (2012) The transport of antiepileptic drugs by P-glycoprotein[J]. Adv Drug Deliv Rev 64(10):930–942

    Article  CAS  PubMed  Google Scholar 

  6. Margineanu DG, Klitgaard H (2009) Mechanisms of drug resistance in epilepsy: relevance for antiepileptic drug discovery. Expert Opin Drug Discov 4(1):23–32

    Article  CAS  PubMed  Google Scholar 

  7. Engel J, McDermott MP, Wiebe S et al (2012) Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial[J]. JAMA 307(9):922–930

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Nunes VD, Sawyer L, Neilson J et al. Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance[J]. BMJ, 2012, 344

  9. Glauser T, Ben-Menachem E, Bourgeois B et al (2013) Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes[J]. Epilepsia 54(3):551–563

    Article  CAS  PubMed  Google Scholar 

  10. Luo G, Cunningham M, Kim S et al (2002) CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes[J]. Drug Metab Dispos 30(7):795–804

    Article  CAS  PubMed  Google Scholar 

  11. Mencarelli A, Renga B, Palladino G et al (2011) Inhibition of NF-κB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells[J]. Eur J Pharmacol 668(1):317–324

    Article  CAS  PubMed  Google Scholar 

  12. Lombardo L, Pellitteri R, Balazy M et al (2008) Induction of nuclear receptors and drug resistance in the brain microvascular edothelial cells treated with antiepileptic drugs. Curr Neurovasc Res 5(2):82–92

    Article  CAS  PubMed  Google Scholar 

  13. Gu, Xinsheng, Ke, Sui, Liu, Duan et al (2006) Role of NF-κB in regulation of PXR-mediated gene expression. A mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem 281(26):882–889

    Article  Google Scholar 

  14. The Ministry of Science and Technology of the People’s Republic of China, Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30

  15. Paxino, G., Watson, C. (2005) The rat Brain in Sterotaxic Coordinates. 5th ed, Elsevier, London

    Google Scholar 

  16. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32(3):281–294

    Article  CAS  PubMed  Google Scholar 

  17. Yu N, Di Q, Liu H, Hu Y, Jiang Y, Yan YK, Zhang YF, Zhang YD (2011) Nuclear factor-kappa B activity regulates brain expression of P-glycoprotein in the kainic acid-induced seizure rats. Mediators Inflamm 2011:670613

    Article  PubMed  PubMed Central  Google Scholar 

  18. Yu N, Liu H, Zhang YF et al (2014) Effects of brain IKKβ gene silencing by small interfering RNA on P-glycoprotein expression and brain damage in the rat Kainic Acid-induced seizure model[J]. Curr Drug Targets-CNS Neurol Disord 13(4):661–672

    Article  CAS  Google Scholar 

  19. Dou W, Zhang J, Zhang E et al (2013) Chrysin ameliorates chemically induced colitis in the mouse through modulation of a PXR/NF-κB signaling pathway[J]. J Pharmacol Exp Ther 345(3):473–482

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Qosa H, Miller DS, Pasinelli P et al (2015) Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders[J]. Brain Res 1628:298–316

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. French JA (2013) P-glycoprotein expression and antiepileptic drug resistance[J]. Lancet Neurol 12(8):732–733

    Article  CAS  PubMed  Google Scholar 

  22. Feldmann M, Asselin MC, Liu J, Koepp MJ (2013) P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study. Lancet Neurol 12(8):777–785

    Article  CAS  PubMed  Google Scholar 

  23. Puranik YG, Birnbaum AK, Marino SE et al (2013) Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy[J]. Pharmacogenomics 14(1):35–45

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Fung KL, Hunt RC, Kimchi-Sarfaty C et al (2016) Genetic polymorphisms of P-glycoprotein: echoes of silence[M]//ABC transporters-40 Years on. Springer, Berlin, p 105–134

  25. Potschka H (2010) Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches[J]. Pharmacogenomics 11(10):1427–1438

    Article  CAS  PubMed  Google Scholar 

  26. Schmidt D, Löscher W (2005) Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms[J]. Epilepsia 46(6):858–877

    Article  CAS  PubMed  Google Scholar 

  27. Zhang B, Xie W, Krasowski MD (2008) PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics 9(11):1695–1709

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Chan G N Y, Hoque M, Cummins CL et al (2011) Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells[J]. J Neurochem 118(2):163–175

    Article  CAS  PubMed  Google Scholar 

  29. Bauer B, Hartz A M S, Lucking JR et al (2008) Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-Ii metabolizing enzyme, GSTπ, at the blood—brain barrier[J]. J Cereb Blood Flow Metab 28(6):1222–1234

    Article  CAS  PubMed  Google Scholar 

  30. Bauer B, Hartz A M S, Fricker G et al (2004) Pregnane X receptor up-regulation of P-glycoprotein expression and transport function at the blood-brain barrier[J]. Mol Pharmacol 66(3):413–419

    CAS  PubMed  Google Scholar 

  31. Owen A, Goldring C, Morgan P et al (2006) Induction of P-glycoprotein in lymphocytes by carbamazepine and rifampicin: the role of nuclear hormone response elements[J]. Br J Clin Pharmacol 62(2):237–242

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Volk H, Potschka H, L ö scher W (2005) Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables. J Histochem Cytochem 53(4):517–531

    Article  CAS  PubMed  Google Scholar 

  33. Roberts DJ, Goralski KB (2008) A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain. Expert Opin Drug Metab Toxicol 4(10):1–20

    Article  Google Scholar 

  34. Yu N, Liu H, Di Q (2013) Modulation of immunity and the inflammatory response: a new target for treating drug-resistant epilepsy[J]. Curr Neuropharmacol 11(1):114–127

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Oscarson M, Zanger UM, Rifki OF et al (2006) Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine[J]. Clin Pharmacol Therapeutics 80(5):440–456

    Article  CAS  Google Scholar 

  36. Malekshah OM, Lage H, Bahrami AR, Afshari JT, Behravan J (2012) PXR and NF- κ B correlate with the inducing effects of IL-1 β and TNF- α on ABCG2 expression in breast cancer cell lines. Eur J Pharm Sci 47(2):474–480

    Article  CAS  PubMed  Google Scholar 

  37. Xu F, Wang F, Yang T et al (2014) Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells[J]. Cancer cell Int 14(1):1

    Article  CAS  Google Scholar 

  38. Taub ME, Podila L, Ely D et al (2005) Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity[J]. Drug Metab Dispos 33(11):1679–1687

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work has been supported by the two grants, one from the National Natural Science Foundation of China (Grant Nos. 81400981, 81171222), and the other one from Nanjing Medical University Science and Technology Development Foundation of China (2013NJMU090).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qing Di.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, N., Zhang, Yf., Zhang, K. et al. Pregnane X Receptor Not Nuclear Factor-kappa B Up-regulates P-glycoprotein Expression in the Brain of Chronic Epileptic Rats Induced by Kainic Acid. Neurochem Res 42, 2167–2177 (2017). https://doi.org/10.1007/s11064-017-2224-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-017-2224-x

Keywords

Navigation